Introducing FoamaDerm™
A novel base for better outcomes
FoamaDerm™ is a propellant-free foam, which is designed as a base for topical diclofenac sodium. FoamaDerm™ is a water based formulation which provides a non-greasy feeling for patient after application and does not stain clothes.
Top 5 reasons to choose FoamaDerm™
1. Patient Tested
Effectiveness of 2% diclofenac in FoamaDerm™ has been tested at the University of Alberta on patients suffering from chronic pain. Click to read the article
2. Better Patient Compliance
Water-based, non-greasy formulation favorable by patients. Also, since low concentrations of drug is used, minimum or no skin irritation happens.
4. Advanced Base,
Enhanced Skin Penetration
FoamaDerm™ is a nanotechnology product, which enhances skin penetration of topical diclofenac.
5. Easy Compounding
Just add diclofenac and mix; no solvents or other tools required. No cleaning required.
3. Better Drug Release Profile
Diclofenac in FoamaDerm™ has better drug release compared to other bases. Click to read the article
Patient demographics and their treatment response to 2% diclofenac in FoamaDerm™. (Ref: adapted from BMC Res Notes 13, 285, 2020)
About Company
We truly see ourselves as your partners in providing solutions tailored to meet your patients' needs. RS Therapeutics Inc. is an Edmonton based company which is dedicated to providing advanced compounding solutions that work.